Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/03/2003WO2002022174A9 A novel cationic lipopolymer as biocompatible gene delivery agent
04/03/2003WO2002018591A9 Method of performing reverse transcription reaction using reverse transcriptase encoded by non-ltr retrotransposable element
04/03/2003WO2002018582A9 62112, a novel human dehydrogenase and uses thereof
04/03/2003WO2002018556A9 8797, a human galactosyltransferase and uses thereof
04/03/2003WO2002017852A3 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
04/03/2003WO2002016645A3 Polymorphic dna fragments and uses thereof
04/03/2003WO2002014526A3 Replication competent aav helper functions
04/03/2003WO2002014468A9 Phage-dependent superproduction of biologically active protein and peptides
04/03/2003WO2002014369A9 Human kininogen d5 domain polypeptides and their use
04/03/2003WO2002012524A3 Adenovirus e1b-55k single amino acid mutants and methods of use
04/03/2003WO2002010420A3 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
04/03/2003WO2002010357A3 Gsk3 polypeptides
04/03/2003WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
04/03/2003WO2002008404A3 Production of lysosomal enzymes in plants by transient expression
04/03/2003WO2002006445A9 Transgenic mice containing targeted gene disruptions
04/03/2003WO2002006326A9 62088, a human nucleoside phosphatase family member and uses thereof
04/03/2003WO2002005930A9 Device and methods for subdividing and filtering gel material and extracting molecules therefrom
04/03/2003WO2002000934A3 Multiply-primed amplification of nucleic acid sequences
04/03/2003WO2002000860A3 Novel proteases
04/03/2003WO2001013268A3 Specific identifiers of amino-acid and base sequences
04/03/2003US20030066108 Novel plant promoter sequences and methods of use for same
04/03/2003US20030066107 Transgenic dunaliella salina as a bioreactor
04/03/2003US20030066104 Genetic engineering; for transgenic plants with altered levels of unsaturated fatty acids
04/03/2003US20030066103 Cytochrome P450 enzyme associated with the synthesis of delta12-epoxy groups in fatty acids of plants
04/03/2003US20030066102 Plant gene for p-hydroxyphenylpyruvate dioxygenase
04/03/2003US20030066101 Genetic engineering; modifying the fibre, starch, nitrogen, non-sulfur containing amino acid, anti-nutritional protein, and/or fatty acid content and/or composition in mono-/dicotylendonous plants
04/03/2003US20030066099 SCCE modified transgenic mammals and their use as models of human disease
04/03/2003US20030066098 Gene expression inhibition; transgenic/animal models
04/03/2003US20030066097 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease
04/03/2003US20030065162 Controlling genetic expression in monocotyledoneous and dicotyledoneous via wheat protein regulatory sequences
04/03/2003US20030065160 Secreted protein HEMAE80
04/03/2003US20030065159 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065158 Propagation of cattle respiratory syncytial virus; propagate cells, insert synthetic nucleotide sequences codiing phosphoprotein into cell, mutate transfered nucleotide sequences, monitor gene expression
04/03/2003US20030065155 Probe for use as diagnostic tool in the detection of single nucleotide polymorphisms
04/03/2003US20030065152 Use of alkanes for contamination-free purification or separation of biopolymers
04/03/2003US20030065151 Secreted protein HCEJQ69
04/03/2003US20030065148 Method for expression of human interferon alpha 1 in Pichia pastoris
04/03/2003US20030065137 Immunological methods to modulate myostatin in vertebrate subjects
04/03/2003US20030065033 Lipid derivatives of polythiourea
04/03/2003US20030064954 Gene therapy; vaccines; calcium channel blockers; cardiovascular disorders
04/03/2003US20030064953 Transferring genes; muscular disorders
04/03/2003US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
04/03/2003US20030064951 Purification; ultrafiltration; gene therapy
04/03/2003US20030064950 Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity
04/03/2003US20030064946 Modulation of gene expression; respiratory system disorders
04/03/2003US20030064945 Modulation of gene expression; anticancer agents
04/03/2003US20030064944 Controlling cell differentiation, cell proliferation
04/03/2003US20030064943 High affinity TGFbeta nucleic acid ligands and inhibitors
04/03/2003US20030064931 Cloning genes; aptamer complex
04/03/2003US20030064919 Novel polypeptides and polynucleotides encoding same
04/03/2003US20030064916 Antigen peptides; medical diagnosis
04/03/2003US20030064908 Amylase variants
04/03/2003US20030064895 Jasmonic acid methyl ester mediating the defensive reactions upon invasion of phytopathogenic organisms and harmful insects; a plant growth regulator; gene encoding the enzyme; recombinant vector; transgenic plant; stress relieving
04/03/2003US20030064517 Expression vectors, transfection systems, and method of use thereof
04/03/2003US20030064516 Circular site-directed mutagenesis
04/03/2003US20030064515 Recombinational cloning using engineered recombination sites
04/03/2003US20030064514 Oligonucleotide for use as antiproliferative agent
04/03/2003US20030064510 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
04/03/2003US20030064509 Novel chromosomal vectors and uses thereof
04/03/2003US20030064499 Enzymatic polypeptide for use in the design of viricides
04/03/2003US20030064495 Human polynucleotides encoding proteins that share sequence similarity with animal kinases; gene expression
04/03/2003US20030064493 Methods and means for modulating PGE synthase activity
04/03/2003US20030064492 Nucleotide sequences for use as tool in human therapeutics and diagnostics
04/03/2003US20030064491 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents
04/03/2003US20030064485 Process for the preparation of D-pantothenic acid and/or salts thereof
04/03/2003US20030064475 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
04/03/2003US20030064472 Stable episomal vectors
04/03/2003US20030064470 Ligand for use as tool in the treatment of tumors in humans
04/03/2003US20030064469 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064468 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064467 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064466 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064464 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064462 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064461 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064460 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064459 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064458 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064457 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064456 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064455 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064451 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064450 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064449 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064448 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064447 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064446 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064445 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064444 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064443 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064442 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064437 Expression system for recombinant proteins
04/03/2003US20030064435 Polypeptide for use in human therapeutics and diagnostics
04/03/2003US20030064432 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer
04/03/2003US20030064431 Complement receptor type 1 (cr1)-like sequences
04/03/2003US20030064430 Novel steroid-activated nuclear receptors and uses therefor
04/03/2003US20030064426 Expression vector for use in the treatment of cancer and age-related defects
04/03/2003US20030064424 Diagnostic test kit for detecting transmissible spongiform encephalopathies